Laura A. Lambert,
MD, FACS
Languages Spoken: English
Dr. Laura Lambert is a Professor of Surgery and Director of the Peritoneal Malignancy Program at the University of Utah. Dr. Lambert specializes in the care of patients requiring surgical treatment related to peritoneal carcinomatosis (cancer which has spread throughout the lining of the abdominal cavity) and gastrointestinal oncology. Dr. Lambert earned her undergraduate degree from Bowdoin College in Brunswick, Maine, and medical degree from Harvard Medical School in Boston Massachusetts. Her general surgery residency was done at the Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire, which was followed by a two-year fellowship in surgical oncology at the University of Texas MD Anderson Cancer Center in Houston, Texas. She obtained her board certification in hospice and palliative medicine in 2012 at the University of Massachusetts in Worcester, Massachusetts. Dr. Lambert joined the faculty at the University of Utah in 2018. Her main clinical focus is the surgical management of peritoneal carcinomatosis and the use of hyperthermic (heated) intraperitoneal chemotherapy (HIPEC). She has published and spoken extensively on HIPEC as well as the surgeon’s role in comprehensive palliative care.
Clinical Locations
801-587-4415
Board Certification and Academic Information
| Academic Departments | Surgery
-
Professor (Clinical) |
| Academic Divisions | General Surgery |
| Board Certification | American Board of Hospice & Palliative Medicine American Board of Surgery |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.9/ 5
Care provider's explanation of condition/problem
5.0/ 5
Care provider's effort to include me in decisions
5.0/ 5
Wait time at clinic
4.7/ 5
Care provider's concern for questions & worries
5.0/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
April 22, 2021
HUNTSMAN CANCER CENTER
Dr. Lambert is a rare, fantastic provider. I am a nurse and have never known a surgeon to be so knowledgeable, personable, and listens to their patients.
UofU Patient
April 17, 2021
HUNTSMAN CANCER CENTER
Dr is good about answering your questions, but there was info she didn't tell me until I asked a specific question. I felt like I had to drag it out of her, to get info.
UofU Patient
March 21, 2021
HUNTSMAN CANCER CENTER
We are so grateful for Dr. Lambert. She has been thorough in her discussions with us.
UofU Patient
March 06, 2021
HUNTSMAN CANCER CENTER
I cannot express how completely impressed I am with her care and abilities. She is AMAZING. Completely professional and thorough.
UofU Patient
February 27, 2021
HUNTSMAN CANCER CENTER
Dr. Lambert was very thorough in her explanation of everything. She is very knowledgeable and gave us input in all our treatment options.
UofU Patient
February 04, 2021
HUNTSMAN CANCER CENTER
The Dr showed me the CT and went over it thoroughly
UofU Patient
December 16, 2020
HUNTSMAN CANCER CENTER
we were highly impressed every single time we met with Dr. Lambert and her team
UofU Patient
December 13, 2020
HUNTSMAN CANCER CENTER
knowledgeable and very helpful
UofU Patient
December 05, 2020
HUNTSMAN CANCER CENTER
Words cannot express how thankful I am for Dr. Lambert. She saved my life. She is AMAZING.
UofU Patient
November 15, 2020
HUNTSMAN CANCER CENTER
I'm so fortunate to be associated with Dr. Lambert and her team.They are wonderful.
UofU Patient
October 06, 2020
HUNTSMAN CANCER CENTER
Dr Lambert shows care and concern. she answered all our questions
UofU Patient
August 19, 2020
HUNTSMAN CANCER CENTER
I really appreciate the time Dr. Lambert took with me and how she helped me to understand the possible surgery we are seeking.
UofU Patient
July 31, 2020
HUNTSMAN CANCER CENTER
Dr. Lambert thoroughly reviewed my CT scans with myself and my family and answered all of our questions.
UofU Patient
June 25, 2020
HUNTSMAN CANCER CENTER
Dr Lambert was very caring and concerned that all my questions were answered and that I understood everything about my proposed treatment. She took lots of time to explain things in a way I could understand. She welcomed questions.
UofU Patient
June 07, 2020
HUNTSMAN CANCER CENTER
dr and nurse just couldn't be more caring
UofU Patient
May 22, 2020
HUNTSMAN CANCER CENTER
Dr Lambert showed incredible professional competence but beyond that, she showed incredible compassion and sympathy as she sat with me and discussed the consequences and care of the surgical procedure I had last week that was a game changer, and with which I have really been struggling. I could not have asked for better care at this visit from her and it was most appreciated.
UofU Patient
April 26, 2020
HUNTSMAN CANCER CENTER
very good
UofU Patient
April 26, 2020
HUNTSMAN CANCER CENTER
Dr. Lambert was awesome
UofU Patient
December 15, 2019
HUNTSMAN CANCER CENTER
I feel very fortunate that Dr. Lambert is my surgical oncologist. Her expertise extended my life and I will forever be grateful. She is very compassionate and professional.
UofU Patient
December 10, 2019
HUNTSMAN CANCER CENTER
Dr Lambert listened to my concerns and answered them to my satisfaction
UofU Patient
December 06, 2019
HUNTSMAN CANCER CENTER
Dr. Lambert is awesome!
UofU Patient
November 17, 2019
HUNTSMAN CANCER CENTER
Dr. Lambert is a caring professional. I have the utmost respect and trust in her. - _____
UofU Patient
October 13, 2019
HUNTSMAN CANCER CENTER
Everything was explained as well as complication possibilities, risks vs rewards.
UofU Patient
October 04, 2019
HUNTSMAN CANCER CENTER
like I mentioned, ______ is not a candidate for surgery right now but even so, Dr. Lambert explained his situation well and told us about a symposium we could attend
UofU Patient
September 29, 2019
HUNTSMAN CANCER CENTER
Good
UofU Patient
August 12, 2019
HUNTSMAN CANCER CENTER
The first visit was positive and very informative. Since then my experience has been frustrating. Scheduled appointments have been canceled (at the last minute) only to have more appointments canceled. My first chemo treatment was schelduled for August 5th and I'm still waiting for a confirmation on when it will be.
UofU Patient
August 02, 2019
HUNTSMAN CANCER CENTER
My Doctor and staff saved my life
UofU Patient
July 15, 2019
HUNTSMAN CANCER CENTER
dr Lambert is the best. she really cares
UofU Patient
June 26, 2019
HUNTSMAN CANCER CENTER
One of the best medical experiences I've had with Dr. Lambert and her staff
UofU Patient
June 23, 2019
HUNTSMAN CANCER CENTER
I appreciated Dr. Lambert's expertise and all of the time she spent with me developing and explaining my health care plan.
UofU Patient
June 13, 2019
HUNTSMAN CANCER CENTER
it was so wonderful to find a doctor with expertise in dealing with my rare cancer
UofU Patient
May 19, 2019
HUNTSMAN CANCER CENTER
I wa very pleased with all dr's and nurses.
UofU Patient
May 10, 2019
HUNTSMAN CANCER CENTER
I was so impressed with the whole crew
UofU Patient
April 01, 2019
HUNTSMAN CANCER CENTER
I feel very fortunate to have Dr. Laura Lambert as my surgical oncologist and her team to tend to my medical needs.
UofU Patient
March 24, 2019
HUNTSMAN CANCER CENTER
I am blessed to have Dr. Laura in my corner. I am comforted by her knowledge, courage and support on my behalf.
UofU Patient
January 31, 2019
HUNTSMAN CANCER CENTER
gave me hope
UofU Patient
January 24, 2019
HUNTSMAN CANCER CENTER
There is not a finer human being than Dr Lambert. I am so grateful to have her consider my case and help me through this journey.
UofU Patient
November 24, 2018
HUNTSMAN CANCER CENTER
I was very happy with the explanations and care that I recieved.
UofU Patient
October 09, 2018
HUNTSMAN CANCER CENTER
Dr. Lambert took time to explain what she thought about my condition and what the best treatment options were right now. She answered questions thoroughly. I felt she was exceptional in her explanations and caring.
UofU Patient
September 30, 2018
HUNTSMAN CANCER CENTER
I am delighted to have Dr. Lambert at Huntsman & such an eminently qualified individual to lead this program! Although I am entering hospice because the cancer did not respond as hoped, I am so happy that the Intermountain states now have a program for the HIPEC that removes "out of area" and "out of network" from the decisions.
UofU Patient
August 07, 2018
HUNTSMAN CANCER CENTER
Very happy with the people I met with. They listened and repeated back what I said. Notes on followup are the same as what I talked about with them, so I know they listened and take my comments into mind when determining what action to take. I'm very confident in their decisions, whatever that will be.
UofU Patient
July 17, 2018
HUNTSMAN CANCER CENTER
I would highly recommend Laura Lambert.
UofU Patient
March 22, 2018
Dr. Lambert has a true gift for talking with her patients. Through her caring manner, she provides objective information that helps the patient make their own difficult health decisions.
Dr. Laura Lambert is a Professor of Surgery and Director of the Peritoneal Malignancy Program at the University of Utah. Dr. Lambert specializes in the care of patients requiring surgical treatment related to peritoneal carcinomatosis (cancer which has spread throughout the lining of the abdominal cavity) and gastrointestinal oncology. Dr. Lambert earned her undergraduate degree from Bowdoin College in Brunswick, Maine, and medical degree from Harvard Medical School in Boston Massachusetts. Her general surgery residency was done at the Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire, which was followed by a two-year fellowship in surgical oncology at the University of Texas MD Anderson Cancer Center in Houston, Texas. She obtained her board certification in hospice and palliative medicine in 2012 at the University of Massachusetts in Worcester, Massachusetts. Dr. Lambert joined the faculty at the University of Utah in 2018. Her main clinical focus is the surgical management of peritoneal carcinomatosis and the use of hyperthermic (heated) intraperitoneal chemotherapy (HIPEC). She has published and spoken extensively on HIPEC as well as the surgeon’s role in comprehensive palliative care.
Academic Locations
Huntsman Cancer Hospital
801-587-4415
Board Certification and Academic Information
| Academic Departments | Surgery
-
Professor (Clinical) |
| Academic Divisions | General Surgery |
| Board Certification | American Board of Hospice & Palliative Medicine American Board of Surgery |
Education History
| Fellowship | University of Texas MD Anderson Cancer Center Surgical Oncology Administrative Fellow |
| Fellowship | University of Texas MD Anderson Cancer Center Surgical Oncology Fellow |
| Chief Resident | Dartmouth-Hitchcock Medical Center General Surgery Chief Resident |
| Residency | Dartmouth-Hitchcock Medical Center General Surgery Resident |
| Internship | Dartmouth-Hitchcock Medical Center General Surgery Intern |
| Professional Medical | Harvard Medical School Medicine M.D. |
| Undergraduate | Bowdoin College German & Economics B.A. |
Selected Publications - Journal Articles
Journal Article
- Kubi B, Nudotor R, Fackche N, Nizam W, Cloyd JM, Grotz TE, Fournier KF, Dineen SP, Powers BD, Veerapong J, Baumgartner JM, Clarke CN, Patel SH, Lambert LA, Abbott DE, Vande Walle KA, Raoof M, Lee B, Maithel SK, Staley CA, Johnston FM, Greer JB (2021). Impact of Perioperative Blood Transfusions on Outcomes After Hyperthermic Intraperitoneal Chemotherapy: A Propensity-Matched Analysis. Ann Surg Oncol, 28(8), 4499-4507.
- Bleicher J, Lambert LA (2021). A Palliative Approach to Management of Peritoneal Carcinomatosis and Malignant Ascites. Surg Oncol Clin N Am, 30(3), 475-490.
- Bleicher J, Lambert LA, Scaife CL, Colonna A (2021). Current management of malignant bowel obstructions: a survey of acute care surgeons and surgical oncologists. Trauma Surg Acute Care Open, 6(1), e000755.
- Bleicher J, Place A, Schoenhals S, Luppens CL, Grudziak J, Lambert LA, McCrum ML (2021). Drivers of Moral Distress in Surgical Intensive Care Providers: A Mixed Methods Study. J Surg Res, 266, 292-299.
- Fackche N, Schmocker RK, Kubi B, Cloyd JM, Ahmed A, Grotz T, Leiting J, Fournier K, Lee AJ, Powers B, Dineen S, Veerapong J, Baumgartner JM, Clarke C, Gamblin TC, Patel SH, Dhar V, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Lafaro K, Lee B, Zaidi MY, Maithel SK, Johnston FM, Greer JB (2021). The Utility of Preoperative Tumor Markers in Peritoneal Carcinomatosis from Primary Appendiceal Adenocarcinoma: an Analysis from the US HIPEC Collaborative. (Epub ahead of print) J Gastrointest Surg.
- Lee RM, Gamboa AC, Turgeon MK, Zaidi MY, Kimbrough C, Leiting J, Grotz T, Lee AJ, Fournier K, Powers B, Dineen S, Baumgartner JM, Veerapong J, Mogal H, Clarke C, Wilson G, Patel S, Hendrix R, Lambert L, Pokrzywa C, Abbott DE, LaRocca CJ, Raoof M, Greer J, Johnston FM, Staley CA, Cloyd JM, Maithel SK, Russell MC (2020). A novel preoperative risk score to optimize patient selection for performing concomitant liver resection with cytoreductive surgery/HIPEC. J Surg Oncol, 123(1), 187-195.
- Powers BD, Felder S, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Staley CA, Maithel SK, Patel S, Dhar V, Lambert L, Hendrix RJ, Abbott DE, Pokrzywa C, Raoof M, Lee B, Johnston FM, Greer J, Cloyd JM, Kimbrough C, Grotz T, Leiting J, Fournier K, Lee AJ, Imanirad I, Dessureault S, Dineen SP (2020). Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Not Associated with Prohibitive Complications: Results of a Multiinstitutional Retrospective Study. Ann Surg Oncol, 27(13), 4883-4891.
- Turgeon MK, Gamboa AC, Lee RM, Zaidi MY, Kimbrough C, Grotz T, Fournier K, Powers B, Dineen S, Veerapong J, Clarke C, Mogal H, Patel SH, Lambert L, Ronnekleiv-Kelly S, Raoof M, Fackche N, Greer JB, Staley CA, Cloyd JM, Maithel SK, Winer JH (2020). The Intersection of Age and Tumor Biology with Postoperative Outcomes in Patients After Cytoreductive Surgery and HIPEC. Ann Surg Oncol, 27(13), 4894-4907.
- Gamboa AC, Lee RM, Turgeon MK, Zaidi MY, Kimbrough CW, Grotz TE, Leiting J, Fournier K, Lee AJ, Dineen SP, Powers BD, Veerapong J, Baumgartner JM, Clarke CN, Mogal H, Patel SH, Lee TC, Lambert LA, Hendrix RJ, Abbott DE, Pokrzywa C, Raoof M, Eng OS, Johnston FM, Greer J, Cloyd JM, Maithel SK, Staley CA (2020). Implications of Postoperative Complications for Survival After Cytoreductive Surgery and HIPEC: A Multi-Institutional Analysis of the US HIPEC Collaborative. Ann Surg Oncol, 27(13), 4980-4995.
- Hbner M, Kusamura S, Villeneuve L, Al-Niaimi A, Alyami M, Balonov K, Bell J, Bristow R, Guiral DC, Fagotti A, Falco LFR, Glehen O, Lambert L, Mack L, Muenster T, Piso P, Pocard M, Rau B, Sgarbura O, Somashekhar SP, Wadhwa A, Altman A, Fawcett W, Veerapong J, Nelson G (2020). Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced Recovery After Surgery (ERAS®) Society Recommendations - Part II: Postoperative management and special considerations. Eur J Surg Oncol, 46(12), 2311-2323.
- Roife D, Powers BD, Zaidi MY, Staley CA, Cloyd JM, Ahmed A, Grotz T, Leiting J, Fournier K, Lee AJ, Veerapong J, Baumgartner JM, Clarke C, Patel SH, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Lee B, Blakely A, Greer J, Johnston FM, Laskowitz D, Dessureault S, Dineen SP (2020). CRS/HIPEC with Major Organ Resection in Peritoneal Mesothelioma Does not Impact Major Complications or Overall Survival: A Retrospective Cohort Study of the US HIPEC Collaborative. Ann Surg Oncol, 27(13), 4996-5004.
- Wiseman JT, Abdel-Misih S, Beal EW, Zaidi MY, Staley CA, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Powers B, Veerapong J, Baumgartner JM, Clarke C, Patel SH, Dhar V, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Raoof M, Eng O, Fackche N, Greer J, Pawlik TM, Cloyd JM (2020). A multi-institutional analysis of Textbook Outcomes among patients undergoing cytoreductive surgery for peritoneal surface malignancies. Surg Oncol, 37, 101492.
- Kubi B, Gunn J, Fackche N, Cloyd JM, Abdel-Misih S, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Dessureault S, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Patel SH, Dhar V, Lambert L, Hendrix RJ, Abbott DE, Pokrzywa C, Raoof M, Lee B, Maithel SK, Staley CA, Johnston FM, Wang NY, Greer JB (2020). Predictors of Non-home Discharge after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. J Surg Res, 255, 475-485.
- Eng OS, Blakely AM, Lafaro KJ, Fournier KF, Fackche NT, Johnston FM, Dineen S, Powers B, Hendrix R, Lambert LA, Ronnekleiv-Kelly S, Walle KV, Grotz TE, Leiting JL, Patel SH, Dhar VK, Baumgartner JM, Lowy AM, Clarke CN, Mogal H, Zaidi MY, Staley CA, Kimbrough C, Cloyd JM, Lee B, Raoof M (2020). Institutional variation in recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: An opportunity for enhanced recovery pathways. J Surg Oncol, 122(5), 980-985.
- Nevo ON, Lambert L (2020). Start the Right Way: A Foundation for Improving Connection to Service and People in Medical Education. Mil Med, 185(Suppl 3), 46-51.
- Leiting JL, Cloyd JM, Ahmed A, Fournier K, Lee AJ, Dessureault S, Felder S, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Staley CA, Zaidi MY, Patel SH, Ahmad SA, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Raoof M, LaRocca CJ, Johnston FM, Greer J, Grotz TE (2020). Comparison of open and closed hyperthermic intraperitoneal chemotherapy: Results from the United States hyperthermic intraperitoneal chemotherapy collaborative. World J Gastrointest Oncol, 12(7), 756-767.
- Beal EW, Suarez-Kelly LP, Kimbrough CW, Johnston FM, Greer J, Abbott DE, Pokrzywa C, Raoof M, Lee B, Grotz TE, Leiting JL, Fournier K, Lee AJ, Dineen SP, Powers B, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Russell MC, Zaidi MY, Patel SH, Dhar V, Lambert L, Hendrix RJ, Hays J, Abdel-Misih S, Cloyd JM (2020). Impact of Neoadjuvant Chemotherapy on the Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Multi-Institutional Retrospective Review. J Clin Med, 9(3).
- Beal EW, Ahmed A, Grotz T, Leiting J, Fournier KF, Lee AJ, Dineen S, Dessureault S, Baumgartner JM, Veerapong J, Clarke C, Strong E, Maithel SK, Zaidi MY, Patel S, Dhar V, Hendrix R, Lambert L, Johnston F, Fackche N, Raoof M, LaRocca C, Ronnekleiv-Kelly S, Pokrzywa C, Pawlik TM, Abdel-Misih S, Cloyd JM (2019). Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Am J Surg, 219(3), 478-483.
- Wiseman JT, Kimbrough C, Beal EW, Zaidi MY, Staley CA, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Powers B, Veerapong J, Baumgartner JM, Clarke C, Patel SH, Dhar V, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Raoof M, Lee B, Fackche N, Greer J, Pawlik TM, Abdel-Misih S, Cloyd JM (2019). Predictors of Anastomotic Failure After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Technique Matter? Ann Surg Oncol, 27(3), 783-792.
- Lee RM, Zaidi MY, Gamboa AC, Speegle S, Kimbrough CW, Cloyd JM, Leiting JL, Grotz TE, Lee AJ, Fournier KF, Powers BD, Dineen SP, Baumgartner J, Veerapong J, Clarke CN, Sussman JJ, Patel S, Hendrix RJ, Lambert LA, Vande Walle KA, Abbott DE, LaRocca CJ, Raoof M, Fackche N, Johnston FM, Staley CA, Maithel SK, Russell MC (2019). What is the Optimal Preoperative Imaging Modality for Assessing Peritoneal Cancer Index? An Analysis From the United States HIPEC Collaborative. Clin Colorectal Cancer, 19(1), e1-e7.
- Gamboa AC, Zaidi MY, Lee RM, Speegle S, Switchenko JM, Lipscomb J, Cloyd JM, Ahmed A, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Powers BD, Lowy AM, Kotha NV, Clarke C, Gamblin TC, Patel SH, Lee TC, Lambert L, Hendrix RJ, Abbott DE, Vande Walle K, Lafaro K, Lee B, Johnston FM, Greer J, Russell MC, Staley CA, Maithel SK (2019). Optimal Surveillance Frequency After CRS/HIPEC for Appendiceal and Colorectal Neoplasms: A Multi-institutional Analysis of the US HIPEC Collaborative. Ann Surg Oncol, 27(1), 134-146.
- Hendrix RJ, Kassira JP, Lambert LA (2019). Elevated Maximum Core Body Temperature During Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) is Associated with Increased Postoperative Complications. Ann Surg Oncol, 27(1), 232-239.
- Levinsky NC, Morris MC, Wima K, Sussman JJ, Ahmad SA, Cloyd JM, Kimbrough C, Fournier K, Lee A, Dineen S, Dessureault S, Veerapong J, Baumgartner JM, Clarke C, Zaidi MY, Staley CA, Maithel SK, Leiting J, Grotz T, Lambert L, Hendrix RJ, Ronnekleiv-Kelly S, Pokrzywa C, Raoof M, Eng OS, Johnston FM, Greer J, Patel SH (2019). Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC Collaborative. J Gastrointest Surg, 24(1), 155-164.
- Zaidi MY, Lee RM, Gamboa AC, Speegle S, Cloyd JM, Kimbrough C, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Dessureault S, Kelly KJ, Kotha NV, Clarke C, Gamblin TC, Patel SH, Lee TC, Hendrix RJ, Lambert L, Ronnekleiv-Kelly S, Pokrzywa C, Blakely AM, Lee B, Johnston FM, Fackche N, Russell MC, Maithel SK, Staley CA 3rd (2019). Preoperative Risk Score for Predicting Incomplete Cytoreduction: A 12-Institution Study from the US HIPEC Collaborative. Ann Surg Oncol, 27(1), 156-164.
- Lee TC, Wima K, Sussman JJ, Ahmad SA, Cloyd JM, Ahmed A, Fournier K, Lee AJ, Dineen S, Powers B, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Zaidi MY, Maithel SK, Leiting J, Grotz T, Lambert L, Hendrix RJ, Abbott DE, Pokrzywa C, Blakely AM, Lee B, Johnston FM, Greer J, Patel SH (2019). Readmissions After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a US HIPEC Collaborative Study. J Gastrointest Surg, 24(1), 165-176.
- Leiting JL, Day CN, Harmsen WS, Cloyd JM, Abdel-Misih S, Fournier K, Lee AJ, Dineen S, Dessureault S, Veerapongh J, Baumgartner JM, Clarke C, Mogal H, Russell MC, Zaidi MY, Patel SH, Morris MC, Hendrix RJ, Lambert LA, Abbott DE, Pokrzywa C, Raoof M, Eng O, Johnston FM, Greer J, Grotz TE (2020). The impact of HIPEC vs. EPIC for the treatment of mucinous appendiceal carcinoma: a study from the US HIPEC collaborative. Int J Hyperthermia, 37(1), 1182-1188.
- Hendrix RJ, Lambert LA (2019). ASO Author Reflections: Intraoperative Fluid Restriction During CRS-HIPEC-Less is More. Ann Surg Oncol, 26(Suppl 3), 575-576.
- Kotha NV, Baumgartner JM, Veerapong J, Cloyd JM, Ahmed A, Grotz TE, Leiting JL, Fournier K, Lee AJ, Dineen SP, Dessureault S, Clarke C, Mogal H, Zaidi MY, Russell MC, Patel SH, Sussman JJ, Dhar V, Lambert LA, Hendrix RJ, Abbott DE, Pokrzywa C, Lafaro K, Lee B, Greer JB, Fackche N, Lowy AM, Kelly KJ (2019). Primary Tumor Sidedness is Predictive of Survival in Colon Cancer Patients Treated with Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A US HIPEC Collaborative Study. Ann Surg Oncol, 26(7), 2234-2240.
- Lambert LA (2019). Invited Commentary. J Am Coll Surg, 228(6), 851.
- Zhu X, Salhab M, Tomaszewicz K, Meng X, Mathew C, Bathini V, Switzer B, Walter O, Cosar EF, Wang X, Lambert LA, Hutchinson LM (2018). Heterogeneous mutational profile and prognosis conferred by TP53 mutations in appendiceal mucinous neoplasms. Hum Pathol, 85, 260-269.
- Hendrix RJ, Damle A, Williams C, Harris A, Spanakis S, Lambert DH, Lambert LA (2018). Restrictive Intraoperative Fluid Therapy is Associated with Decreased Morbidity and Length of Stay Following Hyperthermic Intraperitoneal Chemoperfusion. Ann Surg Oncol, 26(2), 490-496.
- Lambert LA, Wiseman J (2018). Palliative Management of Peritoneal Metastases. Ann Surg Oncol, 25(8), 2165-2171.
- Lambert LA, Hendrix RJ (2018). Palliative Management of Advanced Peritoneal Carcinomatosis. Surg Oncol Clin N Am, 27(3), 585-602.